Skip to main content
Sino Medical Sciences Technology Inc. logo

Sino Medical Sciences Technology Inc. — Investor Relations & Filings

Ticker · 688108 ISIN · CNE100003NY2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2026-02-12 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688108

About Sino Medical Sciences Technology Inc.

https://www.sinomed.com/

Sino Medical Sciences Technology Inc. (SINOMED) specializes in the research, development, and manufacturing of high-end interventional medical devices. The company focuses on cardiovascular, neurovascular, and structural heart disease treatments. Its core product portfolio includes drug-eluting stents (DES) and balloon catheters, notably the BuMA and BuMA Supreme series. SINOMED utilizes proprietary technologies, such as the eG™ coating, to improve clinical outcomes and patient safety. The company maintains a strong commitment to clinical research and international expansion, aiming to provide innovative solutions for minimally invasive procedures.

Recent filings

Filing Released Lang Actions
赛诺医疗科学技术股份有限公司关于第三届董事会独立董事专门会议第七次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of a resolution passed at a specialized meeting of independent directors of the company's third board. It details the approval of a proposal regarding the waiver of a preferential right related to a subsidiary's equity transfer and associated related-party transaction. The document includes voting results and legal compliance statements. It does not contain financial statements, earnings data, or detailed management discussion. It is not a full annual or interim report, nor a call transcript or capital update. It is a formal board/management announcement about a board decision and related transaction approval. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on board meeting resolutions, not a report publication or regulatory filing.
2026-02-12 Chinese
赛诺医疗科学技术股份有限公司关于第三届董事会第十一次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the 11th meeting of the 3rd Board of Directors of Sino Medical Technology Co., Ltd. It details the meeting date, attendance, and voting results on several proposals including capital increase, waiver of preferential rights, and convening a shareholders meeting. The document does not contain financial statements or detailed financial data but rather reports on board decisions and meeting outcomes. It is not a full annual or interim report, nor an earnings release or audit report. It fits the category of Board/Management Information (MANG) as it relates to board meeting resolutions and governance decisions.
2026-02-12 Chinese
报备文件2：赛诺医疗第三届董事会第十一次会议决议
Board/Management Information Classification · 95% confidence The document is a resolution from the company's board of directors meeting, detailing decisions made regarding capital increase, waiver of preferential rights, and calling a shareholders meeting. It is a formal announcement of board decisions rather than a full report or financial statement. The content fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board. The document length is short and does not contain financial statements or detailed financial analysis, so it is not an Annual Report or Interim Report. It is not a regulatory filing or announcement of voting results, but a board meeting resolution.
2026-02-12 Chinese
赛诺医疗科学技术股份有限公司章程（2026.02）
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association (章程) for 赛诺医疗科学技术股份有限公司 (Sino Medical Sciences Technology Inc.). It includes comprehensive sections on company governance, shareholder rights, board structure, share issuance, capital changes, shareholder meetings, and other corporate governance matters. It references Chinese company law, securities law, and regulatory requirements. The content is not a financial report, earnings release, or announcement but a governance document outlining internal rules and procedures. Therefore, it fits the category of Governance Information (CGR). The document length and detail confirm it is the full governance document, not just an announcement or summary.
2026-02-12 Chinese
赛诺医疗科学技术股份有限公司关于公司冠脉产品获得国内医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from the company about receiving a medical device registration certificate from the National Medical Products Administration. It details the product description, registration certificate number, and the impact on the company. There is no financial data, no mention of financial results, no management discussion, no voting results, no regulatory compliance filings, or other report types. The document is a regulatory announcement about a product approval, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like Annual Report, Earnings Release, or Capital Update. The document length is short and it is an announcement, not a report or presentation.
2026-02-04 Chinese
赛诺医疗科学技术股份有限公司2025年度业绩预增公告
Earnings Release Classification · 95% confidence The document is titled as a "2025年度业绩预增公告" which translates to "2025 Annual Performance Forecast Announcement." It provides preliminary financial performance estimates for the full fiscal year 2025, including expected revenue and net profit growth percentages compared to the prior year. The document explicitly states that the financial data are preliminary and unaudited, and it references that the final accurate financial data will be disclosed in the company's formal 2025 Annual Report. The document length is 2082 characters, which is relatively short and consistent with an announcement rather than a full report. There are no detailed financial statements or comprehensive analysis present, only forecasted figures and explanations of expected changes. This fits the profile of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results highlighting key figures and outlook. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks detailed financial statements and is a forecast rather than actual results. It is not a Report Publication Announcement (RPA) because it contains substantive financial forecast data rather than just a notice of report availability. Therefore, the correct classification is Earnings Release (ER). FY 2025
2026-01-30 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.